Clinique Medicale Uro-Gyneco de l'Abitibi
Val-d'Or, Quebec, J9P1W1, Canada
Location status: Recruiting
NCT Number: NCT06389071
Fractional ablative laser treatment for Lichen Sclerosus lesion
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Val-d'Or, Quebec, J9P1W1, Canada
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fractional 2940 nm Laser
Time frame: 16 weeks
Efficacy of the treatment is determined by histological changes measured at 16 weeks post final treatment
Contact information is provided by the study sponsor or research team.
Sciton
Industry
Safety and Efficacy of Ablative Fractional 2940 nm Laser Treatment for Lichen Sclerosus Lesion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720830
Lichen Sclerosus Lesion, Lichen Sclerosus et Atrophicus
Frauenfeld, Thurgau, Switzerland
View Trial Details